Preliminary communicationCognitive control therapy and transcranial direct current stimulation for depression: A randomized, double-blinded, controlled trial
Introduction
Considerable research has been performed on novel treatments for major depression, a chronic, highly prevalent disorder (Kessler et al., 2003) in which antidepressant drugs present modest efficacy (Trivedi et al., 2006) and important adverse effects (Anderson et al., 2008) that limit their use. Some of these novel interventions aim to improve depression symptoms by directly increasing dorsolateral prefrontal cortical (DLPFC) activity, based on the observation of decreased activity of this area and increased activity of subcortical structures observed in MDD, a pattern that is at least partially restored to normal levels after amelioration of depressive symptoms (Mayberg et al., 2000, Pizzagalli, 2011, Siegle et al., 2007). Two of these interventions are particularly appealing considering their low cost, ease of use and applicability in different scenarios: transcranial direct current stimulation (tDCS) and neurocognitive therapies.
TDCS consists of the induction of a weak, direct electric current through electrodes placed over the scalp that could increase (anode) and decrease (cathode) cortical excitability beyond the period of stimulation (Nitsche and Paulus, 2000). Although the exact mechanisms of action of tDCS are still unclear, it probably operates by inducing small changes (<1 mV) in the membrane potential (Datta et al., 2009), thus acting in the frequency of spike timing and modifying net cortical excitability (Purpura and McMurtry, 1965). Compared to repetitive transcranial magnetic stimulation (rTMS), another somatic therapy, tDCS is cheaper, easier to use and a more portable technique with less adverse effects (Priori et al., 2009); characteristics that have motivated further tDCS research in neuropsychiatric disorders, particularly depression. In fact, recent randomized clinical trials demonstrated that daily, repeated sessions of tDCS show clinical efficacy in the treatment of major depression (Brunoni et al., 2013c, Loo et al., 2012). These studies applied anodal tDCS over the left DLPFC, theoretically increasing the activity in this brain area, which is decreased in MDD.
Neurocognitive therapy is an intervention that addresses the biological mechanisms of psychological disorders (Siegle et al., 2007). For depression, current neurocognitive interventions consist of tasks focused on working memory and sustained attention training, as these cognitive tasks are associated with DLPFC activity—in fact, patients with depression have poorer performance in many of these tasks (Barch et al., 2003, Gotlib and Joormann, 2010, Jones et al., 2010). In recent studies, Siegle et al., 2007, Siegle et al., In press investigated whether these interventions that increase DLPFC activity could be employed as a depression treatment. The authors compared the outcome of depressed patients that were randomized to receive treatment as usual only vs. combined with cognitive control therapy (CCT) designed to increase DLPFC activity. They showed that the CCT group displayed significantly greater improvements in depression symptoms than those in the treatment as usual group. In another study, Segrave et al. (2013) explored the efficacy of CCT combined with tDCS in a 3-arm trial, randomizing 27 patients to receive CCT+sham tDCS, tDCS+sham CCT and both active therapies combined, finding that only CCT and tDCS combined presented sustained antidepressant response at follow-up. However, the sample size of this study was small (n=9 per condition) and the number of sessions was limited (5 sessions). These promising results fostered further investigation in this topic.
Both tDCS and CCT might act in depression improvement via enhancement of DLPFC activity. Theoretically, tDCS could enhance – i.e., present synergistic effects – the influence of CCT, based on previous studies that showed that tDCS increases WM performance in healthy and depressed volunteers (Brunoni and Vanderhasselt, 2014, Brunoni and Vanderhasselt, 2014, Fregni et al., 2005, Oliveira et al., 2013). We examined whether tDCS, by increasing cortical activity in the DLPFC, could enhance performance and therefore the effects of CCT, which actively recruits similar brain areas, thus ameliorating depression. Importantly, we used the Paced Auditory Serial Addition Task (PASAT) training alone (and not combined to the computer-based attention training part as used in the Segrave et al. study) for CCT, because by using two tasks it is impossible to disentangle the specific contribution of each task. We used the PASAT because this task is already known to activate the left middle frontal gyrus, including the DLPFC (Lazeron et al., 2003). The importance of this study is both mechanistic – i.e., to increase the understanding of the pathophysiological mechanisms involved in depression – and clinical, as we investigated whether the combination of two non-pharmacological, affordable therapies presented clinical gains in depressed subjects.
Section snippets
Methods
The study was approved by the Local and National Ethics Committee and is registered in clinicaltrials.gov (NCT01434836). All patients provided written, informed consent. The trial was conducted in the University Hospital, University of São Paulo, Brazil and in the Mackenzie Presbyterian University, also situated in São Paulo, Brazil from September 2011 to May 2013.
Results
Approximately 200 potential volunteers were screened to participate in the study. Of them, 160 were excluded, as they did not attend to the eligibility criteria. The included patients were randomized to the active tDCS+CCT and sham tDCS+CCT groups. The groups were similar in clinical and demographic characteristics at baseline (Table 1). Importantly, 3 of the 40 participants were not included in our analyses due to trial abandonment (i.e., did not complete at least 2 visits to our research
Discussion
In this randomized, double-blinded trial assessing the efficacy of cognitive control therapy alone (n=17) and combined with tDCS (n=20) in major depression; CCT alone and combined with tDCS ameliorated depressive symptoms immediately after the acute treatment period (week 2) and at endpoint (week 4). Exploratory analyses revealed a superior improvement in depressive symptoms for the combined therapy when taking into account age and improvement in the PASAT performance throughout the trial.
Conclusion
In this randomized, double-blind, sham-controlled trial we investigated whether tDCS could enhance the efficacy of CCT in the treatment of depression. Our main outcome showed that both groups similarly improved over time. However, exploratory analyses revealed that tDCS augmented the clinical effects of CCT in older individuals, particularly in those who presented improvement in the cognitive task performed throughout the trial. We hypothesize that this combined therapy might be particularly
Role of funding source
None.
Conflict of interest
None.
Acknowledgments
ARB is supported by the following grants: 2013 NARSAD Young Investigator from the Brain & Behavior Research Foundation (Grant Number 20493), 2013 FAPESP Young Researcher from the São Paulo State Foundation (Grant Number 20911-5) and National Council for Scientific and Technological Development (CNPq, Grant Number 470904). We are grateful to Prof. Greg Siegle of Pittsburgh University, United States, for generously providing the CCT paradigm.
References (40)
- et al.
Working memory and prefrontal cortex dysfunction: specificity to schizophrenia compared with major depression
Biol. Psychiatry
(2003) - et al.
Clinical utility of transcranial direct current stimulation (tDCS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials
J. Psychiatr. Res.
(2013) - et al.
tDCS selectively improves working memory in older adults with more education
Neurosci. Lett.
(2012) - et al.
Interactions between transcranial direct current stimulation (tDCS) and pharmacological interventions in the major depressive episode: findings from a naturalistic study
Eur. Psychiatry
(2013) - et al.
Transcranial direct current stimulation for the treatment of Major Depressive Disorder: a summary of preclinical, clinical and translational findings
Prog. Neuropsychopharmacol. Biol. Psychiatry
(2012) - et al.
Working memory improvement with non-invasive brain stimulation of the dorsolateral prefrontal cortex: a systematic review and meta-analysis
Brain Cogn.
(2014) - et al.
Transcranial DC stimulation (tDCS): a tool for double-blind sham-controlled clinical studies in brain stimulation
Clin. Neurophysiol.
(2006) - et al.
Speech facilitation by left inferior frontal cortex stimulation
Curr. Biol.: CB
(2011) - et al.
A paced visual serial addition test for fMRI
J. Neurol. Sci.
(2003) - et al.
Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response
Biol. Psychiatry
(2000)